PSA Free (Prostate Cancer)

PSA Free (Prostate Cancer) is a cancer screening markers biomarker that More specific prostate cancer marker The normal reference range is Free/Total PSA ratio >25% suggests benign disease. Regular testing helps track changes and identify potential health issues early.

1 out of 10 major blood testing providers include PSA Free (Prostate Cancer) in their standard panels. These include Superpower.

For most people, testing PSA Free (Prostate Cancer) 2-4 times per year is recommended to establish baseline levels and track trends. If you have abnormal results or are actively working to optimize this biomarker, more frequent testing (quarterly) may be beneficial. Always consult with your healthcare provider for personalized testing frequency recommendations.

The standard laboratory reference range for PSA Free (Prostate Cancer) is Free/Total PSA ratio >25% suggests benign disease. However, many functional medicine practitioners recommend tighter "optimal" ranges for peak health and performance. Your ideal range may vary based on your age, sex, health goals, and other individual factors. Work with a healthcare provider familiar with optimal ranges to determine your target levels.

Most direct-to-consumer blood testing services that include PSA Free (Prostate Cancer) provide the physician order as part of their service. However, some states have restrictions on direct-to-consumer testing. Check with your chosen provider about availability in your state and whether they provide the necessary physician authorization.

Helps distinguish benign prostate enlargement from cancer. Higher percentage of free PSA suggests benign condition. Used with total PSA for better specificity.